Discrepancies between FDA documents and ClinicalTrials.gov for Orphan Drug-related clinical trial data.
Clinical trial registries such as ClinicalTrials.gov (CTG) hold large amounts of data regarding trials. Drugs for rare diseases are known as orphan drugs (ODs), and it is particularly important that trials for ODs are registered, and the data in the trial record are accurate. However, there may be d...
Main Authors: | Mohua Chakraborty Choudhury, Indraneel Chakraborty, Gayatri Saberwal |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2022-01-01
|
Series: | PLOS Global Public Health |
Online Access: | https://doi.org/10.1371/journal.pgph.0000261 |
Similar Items
-
Discrepancies between FDA documents and ClinicalTrials.gov for Orphan Drug-related clinical trial data
by: Mohua Chakraborty Choudhury, et al.
Published: (2022-01-01) -
Facilitating audits of clinical trial data using documents of the Food and Drug Administration
by: Gayatri Saberwal, et al.
Published: (2022-12-01) -
Rare disease patients in India are rarely involved in international orphan drug trials
by: Monoswi Chakraborty, et al.
Published: (2022-01-01) -
Rare disease patients in India are rarely involved in international orphan drug trials.
by: Monoswi Chakraborty, et al.
Published: (2022-01-01) -
Some data quality issues at ClinicalTrials.gov
by: Neha Chaturvedi, et al.
Published: (2019-06-01)